| Molecular Formula | C14H12F6N2O
|
| Molar Mass | 338.25 |
| Density | 1.45±0.1 g/cm3(Predicted) |
| Melting Point | 108 - 111°C |
| Boling Point | 439.9±45.0 °C(Predicted) |
| Solubility | Acetone (Slightly), Chloroform (Slightly, Heated), Methanol (Slightly) |
| Appearance | A crystalline solid |
| Color | White to Pale Beige |
| pKa | 12.06±0.20(Predicted) |
| Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| Stability | Hygroscopic |
| In vivo study | In animal models, LGD-4033 has anabolic activity in muscle, suppressive resorption and anabolic activity in bone, and is more selective in muscle than in prostate. At the concentrations tested, LGD-4033 was safe and well-tolerated, with a long elimination half-life of about 24-36 hours and a linear pharmacokinetics profile. |
